title: [Current therapy of multiple sclerosis: are there indications for intravenous immunoglobulins?].
authors.affiliation: Max-Planck-Institut für Psychiatrie, Abteilung Neuroimmunologie, Martinsried, München.
authors.forename: S
authors.initials: S
authors.lastname: Schmidt
authors.forename: R
authors.initials: R
authors.lastname: Hohlfeld
mesh_terms: D002986:Clinical Trials as Topic; D006801:Humans; D007116:Immunization, Passive / Q000009:adverse effects; D009103:Multiple Sclerosis / Q000209:etiology / Q000628:therapy*; D016896:Treatment Outcome
vernacular_title: Aktuelle Therapie der multiplen Sklerose: Gibt es Indikationen für intravenöse Immunglobuline?